Lubiprostone for Chronic Idiopathic Constipation Treatment

NCT02729909 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

Constipation

Interventions

DRUG: Lubiprostone
DRUG: Placebo

Sponsor

Takeda